Business Context and Reporting Period
This Form 8-K filing by Healthcare Trust of America, Inc. (HTA) and its operating partnership, Healthcare Trust of America Holdings, LP, reports events occurring on June 8 and June 9, 2017. The filing details the partial closing of the "Duke Acquisition," a strategic transaction to acquire medical office building properties and a development platform from Duke Realty Limited Partnership and affiliates, originally announced on May 1, 2017.
Key Financial Metrics and Transaction Details
- Asset Acquisition: Closed on 44 assets (the "Closing Assets") for a total purchase price of approximately $1.4 billion in cash, less a credit of approximately $50 million.
- Financing Structure: The acquisition was funded through:
- Proceeds from the issuance of Class A common stock on May 8, 2017.
- Proceeds from a new debt offering (detailed below).
- $286 million in seller financing secured by 11 of the Closing Assets.
- Debt Issuance: On June 8, 2017, the Operating Partnership issued $900 million in aggregate principal amount of senior unsecured notes:
- $400 million of 2.950% Senior Notes due 2022 (issued at 99.938% of principal).
- $500 million of 3.750% Senior Notes due 2027 (issued at 99.492% of principal).
- Portfolio Status: Of the 78 total assets in the Duke Acquisition, 63 have been closed (44 in this transaction and 19 previously). 15 assets remain subject to rights of first offer/refusal (ROFO/ROFR).
Material Changes and Status of Acquisition
The filing represents a significant expansion of the Company's portfolio through the Duke Acquisition. While 63 of the 78 targeted assets have been acquired, 15 assets valued at approximately $446 million remain subject to outstanding ROFO/ROFR rights. The Company expects that ROFO/ROFR assets valued at approximately $400 million to $500 million will ultimately be exercised. The filing does not provide specific revenue, profit, or cash flow metrics for the reporting period, as it focuses on the transaction mechanics and debt issuance rather than operational results.
Guidance, Outlook, and Risks
Outlook: Management expects to exercise rights on approximately $400 million to $500 million of the remaining ROFO/ROFR assets. The Company intends to integrate the Duke Assets into its existing portfolio.
Risks and Contingencies: The filing includes extensive forward-looking statements subject to risks including:
- Ability to consummate the remaining portions of the Duke Acquisition.
- Effectiveness of deploying capital and integrating new assets.
- Changes in economic conditions affecting the healthcare property and credit markets.
- Financial stability of tenants and fluctuations in third-party payer reimbursements (Medicare/Medicaid).
- Changes in interest rates and availability of capital.
- Compliance with REIT qualification requirements.
Investor Verification Checklist
- Verify the final count and valuation of assets acquired under the Duke Acquisition once all ROFO/ROFR rights are resolved.
- Review the specific terms of the $286 million seller financing arrangement and its impact on leverage ratios.
- Monitor the Company's ability to service the new $900 million debt obligation alongside existing indebtedness.
- Assess the integration progress of the 63 newly acquired assets into the Company's operational platform.
- Confirm the status of the remaining 15 ROFO/ROFR assets and the likelihood of their acquisition.